Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $9.76 Million - $12.9 Million
134,521 Added 248.07%
188,747 $18 Million
Q3 2023

Nov 09, 2023

BUY
$69.28 - $93.38 $3.76 Million - $5.06 Million
54,226 New
54,226 $3.76 Million
Q4 2022

Feb 13, 2023

SELL
$68.3 - $87.44 $9.46 Million - $12.1 Million
-138,438 Reduced 93.41%
9,762 $728,000
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $12.2 Million - $15.9 Million
148,200 New
148,200 $12.2 Million
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $1.28 Million - $1.57 Million
-12,040 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $404,230 - $482,162
3,928 Added 48.42%
12,040 $1.36 Million
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $4.38 Million - $5.47 Million
-52,233 Reduced 86.56%
8,112 $840,000
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $2.45 Million - $2.83 Million
31,158 Added 106.75%
60,345 $5.05 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $1.11 Million - $1.48 Million
19,227 Added 193.04%
29,187 $2.02 Million
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $16,404 - $25,353
313 Added 3.24%
9,960 $1.88 Million
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $691,689 - $791,922
9,647 New
9,647 $2.25 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $632,610 - $775,269
-10,278 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $1.41 Million - $1.63 Million
-25,275 Reduced 71.09%
10,278 $1.9 Million
Q1 2019

May 15, 2019

BUY
$47.89 - $64.05 $1.24 Million - $1.66 Million
25,893 Added 268.04%
35,553 $6.8 Million
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $448,320 - $550,040
9,660 New
9,660 $1.48 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.